Mantle cell lymphoma displays a homogenous methylation profile: A comparative analysis with chronic lymphocytic leukemia

American Journal of Hematology

Volumn 87, Issue 4, 2012, Pages 361-367

  Halldórsdóttir, Anna Margrét ^a   Kanduri, Meena ^a   Marincevic, Millaray ^a   Mansouri, Larry ^a   Isaksson, Anders ^a   Göransson, Hanna ^a   Axelsson, Tomas ^a   Agarwal, Prasoon ^a   Jernberg Wiklund, Helena ^a   Stamatopoulos, Kostas ^b   Sander, Birgitta ^c   Ehrencrona, Hans ^a,d   Rosenquist, Richard ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b G PAPANICOLAOU HOSPITAL   (Greece)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR RECEPTOR RELATED FACTOR 1;

APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE CLUSTER; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CORRELATION; HOMEOBOX; HUMAN; HUMAN CELL; MANTLE CELL LYMPHOMA; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PYROSEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS REGULATORY PROTEINS; AZACITIDINE; CELL DIVISION; CELL LINE, TUMOR; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, HOMEOBOX; GENES, IMMUNOGLOBULIN; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; IMMUNOGLOBULIN HEAVY CHAINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, MANTLE-CELL; MALE; NEOPLASM PROTEINS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 84858299204     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23115     Document Type: Article

References (49)

1. Swerdlow SH, Campo E, Harris N, editors. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissue. Lyon, France: World Health Organization; 2008.
2. Herrmann A, Hoster E, Zwingers T, et al. Improvement of overall survival in advanced stage mantle cell lymphoma. J Clin Oncol 2009; 27: 511-518.
3. Banks PM, Chan J, Cleary ML, et al. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 1992; 16: 637-640.
4. Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: Perspectives for new targeted therapeutics. Nat Rev Cancer 2007; 7: 750-762.
5. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003; 3: 185-197.
6. Hamblin TJ, Davis Z, Gardiner A, et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848-1854.
7. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840-1847.
8. Tobin G, Thunberg U, Johnson A, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: Implicating recognition of a common antigen epitope. Blood 2003; 101: 4952-4957.
9. Tobin G, Thunberg U, Karlsson K, et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004; 104: 2879-2885.
10. Messmer BT, Albesiano E, Efremov DG, et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 2004; 200: 519-525.
11. Stamatopoulos K, Belessi C, Moreno C, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood 2007; 109: 259-270.
12. Bomben R, Dal Bo M, Capello D, et al. Molecular and clinical features of chronic lymphocytic leukemia with stereotyped B cell receptors: Results from an Italian multicentre study. Br J Hematol 2009; 144: 492-506.
13. Martin-Subero JI, Ammerpohl O, Bibikova M, et al. A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS One 2009; 4: e6986.
14. Rush LJ, Raval A, Funchain P, et al. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res 2004; 64: 2424-2433.
15. Kanduri M, Cahill N, Goransson H, et al. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood 2010; 115: 296-305.
16. Leshchenko VV, Kuo PY, Shaknovich R, et al. Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma. Blood 2010; 116: 1025-1034.
17. Enjuanes A, Fernandez V, Hernandez L, et al. Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma. PLoS One 2011; 6: e19736.
18. Rahmatpanah FB, Carstens S, Guo J, et al. Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior. Leukemia 2006; 20: 1855-1862.
19. Halldorsdottir AM, Sander B, Goransson H, et al. High-resolution genomic screening in mantle cell lymphoma-Specific changes correlate with genomic complexity, the proliferation signature and survival. Genes Chromosomes Cancer 2010; 50: 113-121.
20. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008; 111: 5446-5456.
21. Benjamini Y, Hochberg Y. Controlling the false discovery rate-A new and powerful approach to multiple testing. J R Stat Soc B 1995; 57: 289-300.
22. Sturn A, Quackenbush J, Trajanoski Z. Genesis: Cluster analysis of microarray data. Bioinformatics 2002; 18: 207-208.
23. Coffelt SB, Waterman RS, Florez L, et al. Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion. Int J Cancer 2008; 122: 1030-1039.
24. Heilborn JD, Nilsson MF, Jimenez CI, et al. Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Int J Cancer 2005; 114: 713-719.
25. Singha PK, Yeh IT, Venkatachalam MA, Saikumar P. Transforming growth factor-beta (TGF-beta)-inducible gene TMEPAI converts TGF-beta from a tumor suppressor to a tumor promoter in breast cancer. Cancer Res 2010; 70: 6377-6383.
26. Jares P, Campo E. Advances in the understanding of mantle cell lymphoma. Br J Hematol 2008; 142: 149-165.
27. Martinez N, Camacho FI, Algara P, et al. The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival. Cancer Res 2003; 63: 8226-8232.
28. Rajendram R, Ferreira JC, Grafodatskaya D, et al. Assessment of methylation level prediction accuracy in methyl-DNA immunoprecipitation and sodium bisulfite based microarray platforms. Epigenetics 2011; 6:410-415.
29. Lind GE, Skotheim RI, Fraga MF, et al. Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1). J Pathol 2006; 210: 441-449.
30. Rauch T, Wang Z, Zhang X, et al. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci USA 2007; 104: 5527-5532.
31. Rodriguez BA, Cheng AS, Yan PS, et al. Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer. Carcinogenesis 2008; 29: 1459-1465.
32. Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer 2010; 10: 361-371.
33. Ringrose L, Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet 2004; 38: 413-443.
34. Islam TC, Asplund AC, Lindvall JM, et al. High level of cannabinoid receptor 1, absence of regulator of G protein signaling 13 and differential expression of Cyclin D1 in mantle cell lymphoma. Leukemia 2003; 17: 1880-1890.
35. von Haussen J, Koczulla R, Shaykhiev R, et al. The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. Lung Cancer 2008; 59: 12-23.
36. Ek S, Hogerkorp CM, Dictor M, et al. Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells. Cancer Res 2002; 62: 4398-4405.
37. Jackson RSII, Cho YJ, Stein S, Liang P. CYFIP2, a direct p53 target, is leptomycin-B sensitive. Cell Cycle 2007; 6: 95-103.
38. Moll UM, Marchenko N, Zhang XK. p53 and Nur77/TR3-Transcription factors that directly target mitochondria for cell death induction. Oncogene 2006; 25: 4725-4743.
39. Polyak K, Xia Y, Zweier JL, et al. A model for p53-induced apoptosis. Nature 1997; 389: 300-305.
40. Korz C, Pscherer A, Benner A, et al. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. Blood 2002; 99: 4554-4561.
41. Kim KC, Geng L, Huang S. Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res 2003; 63: 7619-7623.
42. Steele-Perkins G, Fang W, Yang XH, et al. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev 2001; 15: 2250-2262.
43. Du Y, Carling T, Fang W, et al. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res 2001; 61: 8094-8099.
44. Lal G, Padmanabha L, Smith BJ, et al. RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma. Cancer 2006; 107: 2752-2759.
45. Shang C, Guo Y, Fu S, et al. SH3GL2 gene participates in MEK-ERK signal pathway partly by regulating EGFR in the laryngeal carcinoma cell line Hep2. Med Sci Monit 2010; 16: BR168-BR173.
46. Ghosh A, Ghosh S, Maiti GP, et al. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: Correlation with HPV infection and tobacco habit. J Pathol 2009; 217: 408-419.
47. Shikauchi Y, Saiura A, Kubo T, et al. SALL3 interacts with DNMT3A and shows the ability to inhibit CpG island methylation in hepatocellular carcinoma. Mol Cell Biol 2009; 29: 1944-1958.
48. Doi A, Park IH, Wen B, et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009; 41: 1350-1353.
49. Irizarry RA, Ladd-Acosta C, Wen B, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41: 178-186.